Acorda Therapeutics Shares Down 41.6% Since SmarTrend's Sell Call (ACOR)
May 25, 2017 at 14:00 PM EDT
SmarTrend identified a Downtrend for Acorda Therapeutics (NASDAQ:ACOR) on March 24th, 2017 at $25.35. In approximately 2 months, Acorda Therapeutics has returned 41.62% as of today's recent price of...
